column
Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment
Lin Zhang, Dongna Li, Pengrong Yi, Jiangwei Shi, Mengqing Guo, Qingsheng Yin, Dingbin Liu, Pengwei Zhuang, Yanjun Zhang,
2023, 13(7):2817-2825. DOI:10.1016/j.apsb.2023.03.018
Abstract
Emerging roles of Aurora-A kinase in cancer therapy resistance
Dayong Zheng, Jun Li, Han Yan, Gang Zhang, Wei Li, Edward Chu, Ning Wei,
2023, 13(7):2826-2843. DOI:10.1016/j.apsb.2023.03.013
Abstract
Phototriggered structures: Latest advances in biomedical applications
Mojtaba Shamsipur, Atefeh Ghavidast, Afshin Pashabadi,
2023, 13(7):2844-2876. DOI:10.1016/j.apsb.2023.04.005
Abstract
Application of microfluidic technologies on COVID-19 diagnosis and drug discovery
Zhun Lin, Zhengyu Zou, Zhe Pu, Minhao Wu, Yuanqing Zhang,
2023, 13(7):2877-2896. DOI:10.1016/j.apsb.2023.02.014
Abstract
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
Junwoo Lee, Dongwoo Khang,
2023, 13(7):2897-2925. DOI:10.1016/j.apsb.2022.11.022
Abstract
Newly developed gas-assisted sonodynamic therapy in cancer treatment
Meng Pan, Danrong Hu, Liping Yuan, Yan Yu, Yicong Li, Zhiyong Qian,
2023, 13(7):2926-2954. DOI:10.1016/j.apsb.2022.12.021
Abstract
Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
Yi-Zheng Fang, Li Jiang, Qiaojun He, Ji Cao, Bo Yang,
2023, 13(7):2955-2962. DOI:10.1016/j.apsb.2023.02.019
Abstract
Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I
Qiaobo Xie, Yanyan Chu, Wenmin Yuan, Yanan Li, Keqin Li, Xinfeng Wu, Xiaohui Liu, Rui Xu, Shuxiang Cui, Xianjun Qu,
2023, 13(7):2963-2975. DOI:10.1016/j.apsb.2023.04.001
Abstract
GPRC5B protects osteoarthritis by regulation of autophagy signaling
Liang He, Ziwei Xu, Xin Niu, Rong Li, Fanhua Wang, Yu You, Jingduo Gao, Lei Zhao, Karan M. Shah, Jian Fan, Mingyao Liu, Jian Luo,
2023, 13(7):2976-2989. DOI:10.1016/j.apsb.2023.05.014
Abstract
Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial-mesenchymal transition via directly targeting TGFβR1
Jingnan Zhang, Ze Zhang, Zhenlin Huang, Manlin Li, Fan Yang, Zeqi Wu, Qian Guo, Xiyu Mei, Bin Lu, Changhong Wang, Zhengtao Wang, Lili Ji,
2023, 13(7):2990-3007. DOI:10.1016/j.apsb.2023.05.006
Abstract
Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window
Shuai Xiong, Hui Xiao, Meng Sun, Yunjie Liu, Ling Gao, Ke Xu, Haiying Liang, Nan Jiang, Yuhui Lin, Lei Chang, Haiyin Wu, Dongya Zhu, Chunxia Luo,
2023, 13(7):3008-3026. DOI:10.1016/j.apsb.2023.05.012
Abstract
A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
Luchen Sun, Nanfei Yang, Bing Chen, Yuncheng Bei, Zisheng Kang, Can Zhang, Nan Zhang, Peipei Xu, Wei Yang, Jia Wei, Jiangqiong Ke, Weijian Sun, Xiaokun Li, Pingping Shen,
2023, 13(7):3027-3042. DOI:10.1016/j.apsb.2023.05.007
Abstract
SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor
Yiqun Li, Mingrui Yang, Yanan Nan, Jiaming Wang, Sanjiao Wang, Dongxiao Cui, Jiajian Guo, Pengfei He, Wenxin Dai, Shuqi Zhou, Yue Zhang, Wenfu Ma,
2023, 13(7):3043-3053. DOI:10.1016/j.apsb.2023.04.007
Abstract
Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability
Ya-Li Sang, Christophe Pannecouque, Erik De Clercq, Shuai Wang, Fen-Er Chen,
2023, 13(7):3054-3066. DOI:10.1016/j.apsb.2023.03.022
Abstract
Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
Zhiwen Li, Zhihao Guo, Xi Lu, Xican Ma, Xiukun Wang, Rui Zhang, Xinxin Hu, Yanxiang Wang, Jing Pang, Tianyun Fan, Yonghua Liu, Sheng Tang, Haigen Fu, Jingpu Zhang, Yinghong Li, Xuefu You, Danqing Song,
2023, 13(7):3067-3079. DOI:10.1016/j.apsb.2023.03.002
Abstract
Controlling antifungal activity with light: Optical regulation of fungal ergosterol biosynthetic pathway with photo-responsive CYP51 inhibitors
Zhuang Li, Na Liu, Wanzhen Yang, Jie Tu, Yahui Huang, Wei Wang, Chunquan Sheng,
2023, 13(7):3080-3092. DOI:10.1016/j.apsb.2023.02.008
Abstract
Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells
Xiangshi Sun, Xiaoxuan Xu, Jue Wang, Xinyue Zhang, Zitong Zhao, Xiaochen Liu, Guanru Wang, Lesheng Teng, Xia Chen, Dangge Wang, Yaping Li,
2023, 13(7):3093-3105. DOI:10.1016/j.apsb.2023.02.002
Abstract
Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator
Jingwen Dong, Chenfei Zhu, Ying Huang, Quanhao Li, Jing Li, Zheng Wang, Yixin Wang, Zhanwei Zhou, Minjie Sun,
2023, 13(7):3106-3120. DOI:10.1016/j.apsb.2022.12.012
Abstract
A rationally designed cancer vaccine based on NIR-II fluorescence image-guided light-triggered remote control of antigen cross-presentation and autophagy
Aihua Wu, Afeng Yang, Qinli Tong, Guoguang Wei, Sihang Zhang, Sheng Yu, Chen Zhang, Jiaojiao Xu, Wei Lu,
2023, 13(7):3121-3136. DOI:10.1016/j.apsb.2022.11.027
Abstract
Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment
Lin Hou, Xueyuan Peng, Ruiting Wang, Yifei Wang, Hong Li, Huijuan Zhang, Yun Zhang, Zhenzhong Zhang,
2023, 13(7):3137-3152. DOI:10.1016/j.apsb.2022.12.014
Abstract
A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression
Yi Zhou, Yingling Miao, Qiudi Huang, Wenwen Shi, Jiacui Xie, Jiachang Lin, Pei Huang, Chengfeng Yue, Yuan Qin, Xiyong Yu, He Wang, Linghao Qin, Jianhai Chen,
2023, 13(7):3153-3167. DOI:10.1016/j.apsb.2022.11.024
Abstract
A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
Letian Li, Jiayi Hao, Yuhang Jiang, Pengfei Hao, Yuwei Gao, Jing Chen, Guoqing Zhang, Ningyi Jin, Maopeng Wang, Chang Li,
2023, 13(7):3168-3176. DOI:10.1016/j.apsb.2023.01.005
Abstract
Author correction to “DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS-STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis” [Acta Pharmaceutica Sinica B 12 (2022) 262-273]
Yuanyuan Wang, Bin Wei, Danping Wang, Jingjing Wu, Jianhua Gao, Haiqing Zhong, Yang Sun, Qiang Xu, Wen Liu, Yanhong Gu, Wenjie Guo,
2023, 13(7):3177-3177. DOI:10.1016/j.apsb.2023.05.008
Abstract
Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]
Fangfang Lai, Ming Ji, Lei Huang, Yunchen Wang, Nina Xue, Tingting Du, Kai Dong, Xiaoqing Yao, Jing Jin, Zhiqiang Feng, Xiaoguang Chen,
2023, 13(7):3178-3179. DOI:10.1016/j.apsb.2023.05.003
Abstract
Erratum to “Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe” [Acta Pharmaceutica Sinica B 13 (2023) 2056-2070]
Hongjuan Zhang, Ying Chen, Yu Zhang, Luyao Qiao, Xiangyin Chi, Yanxing Han, Yuan Lin, Shuyi Si, Jiandong Jiang,
2023, 13(7):3180-3180. DOI:10.1016/j.apsb.2023.05.037
Abstract

Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica